The results showed that neither IRAK4 kinase inhibition nor degradation resulted in cell death or growth inhibition, suggesting that the role of IRAK4 in the survival of ABC DLBCL cells was redundant. Here, IRAK4 is linked to diffuse large B-cell lymphoma.